Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 2
2(40.0%)
5Total
N/A(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06101745Phase 2Recruiting

Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery

Role: collaborator

NCT06853158Not ApplicableRecruiting

MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease

Role: collaborator

NCT05733767Phase 2Recruiting

Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study

Role: collaborator

NCT07211373Not ApplicableEnrolling By Invitation

Advancing Student Suicide Interventions With Scalable Technologies

Role: collaborator

NCT07028892Not ApplicableNot Yet Recruiting

Gamified Learning for Pressure Injury Prevention

Role: collaborator

All 5 trials loaded